Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | 0.00% | 0.00% | -99.76% |
26/04 | Motion for Asset Sale Approved for Biocept, Inc. | CI |
02/04 | Motion for Asset Sale Approved for Biocept, Inc. | CI |
Business Summary
Number of employees: 50
Sales per Business
USD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Commercial
99.1
%
| 61 | 99.5 % | 26 | 99.1 % | -57.96% |
Development Services
0.9
%
| 0 | 0.2 % | 0 | 0.9 % | +63.27% |
Kits and Specimen Collection Tubes (SCT)
0.0
%
| 0 | 0.3 % | 0 | 0.0 % | -98.83% |
Sales per region
USD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 61 | 100.0 % | 26 | 100.0 % | -57.78% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Barbara Blouw
CTO | Chief Tech/Sci/R&D Officer | - | 01/20/01 |
Nathaniel Sweed
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Operating Officer | 60 | 08/22/08 | |
Darrell Taylor
CMP | Compliance Officer | 59 | 10/22/10 |
Robert Walsh
AUD | Comptroller/Controller/Auditor | 31 | 01/22/01 |
David Karlander
PRN | Corporate Officer/Principal | - | 03/21/03 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 2,626,026 | 2,626,006 ( 100.00 %) | 0 | 100.00 % |
Stock B | 0 | 2,090 | 0 | 0 |
Company contact information
Sector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
-99.76% | 262 | |
+1.39% | 12.8B | |
-10.29% | 7.61B | |
+2.92% | 5.41B | |
-1.16% | 4.51B | |
+6.72% | 4.49B | |
+12.21% | 2.73B | |
-15.51% | 2.02B | |
-11.50% | 1.73B | |
-3.53% | 1.64B |
- Stock Market
- Equities
- BIOCQ Stock
- Company Biocept, Inc.